Per Stirling Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,279
Closed -$271K 267
2024
Q3
$271K Hold
2,279
0.04% 231
2024
Q2
$325K Hold
2,279
0.05% 198
2024
Q1
$293K Buy
2,279
+321
+16% +$41.2K 0.05% 195
2023
Q4
$203K Buy
+1,958
New +$203K 0.04% 201